| scholarly article | Q13442814 |
| P50 | author | Christopher D Buckley | Q87865766 |
| P2093 | author name string | Mike Salmon | |
| Helen Williams | |||
| Oliver Haworth | |||
| Andrew Filer | |||
| Alison Cartwright | |||
| Caroline Schmutz | |||
| Jim Middleton | |||
| John H H Williams | |||
| P2860 | cites work | Cutting edge: identification of the orphan chemokine receptor GPR-9-6 as CCR9, the receptor for the chemokine TECK | Q22009485 |
| Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis | Q22010731 | ||
| CCR9A and CCR9B: two receptors for the chemokine CCL25/TECK/Ck beta-15 that differ in their sensitivities to ligand | Q22011099 | ||
| Synovial tissue macrophage populations and articular damage in rheumatoid arthritis | Q70859981 | ||
| Remarkable elevation of interleukin 6 and interleukin 8 levels in the bone marrow serum of patients with rheumatoid arthritis | Q71641544 | ||
| Phenotypic characteristics of bone marrow cells in patients with rheumatoid arthritis | Q72354915 | ||
| Selective lymphocyte chemokine receptor expression in the rheumatoid joint | Q77406819 | ||
| CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis | Q78387171 | ||
| Inflammation and atherosclerosis | Q80015206 | ||
| Induction of a CXCL8 binding site on endothelial syndecan-3 in rheumatoid synovium | Q80955807 | ||
| Expression of chemokine receptors in normal and inflamed human intestine, tonsil, and liver--an immunohistochemical analysis with new monoclonal antibodies from the 8th international workshop and conference on human leucocyte differentiation antigen | Q81265018 | ||
| Premature expression of chemokine receptor CCR9 impairs T cell development | Q81645784 | ||
| TECK: a novel CC chemokine specifically expressed by thymic dendritic cells and potentially involved in T cell development | Q24309326 | ||
| Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity | Q24676033 | ||
| Chemokine receptors in the rheumatoid synovium: upregulation of CXCR5 | Q24803643 | ||
| The chemokine TECK is expressed by thymic and intestinal epithelial cells and attracts double- and single-positive thymocytes expressing the TECK receptor CCR9 | Q28140646 | ||
| The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune system | Q28142045 | ||
| Selectively increased expression and functions of chemokine receptor CCR9 on CD4+ T cells from patients with T-cell lineage acute lymphocytic leukemia | Q28209933 | ||
| Macrophages and their products in rheumatoid arthritis | Q28296955 | ||
| Expression and functional role of CCR9 in prostate cancer cell migration and invasion | Q28300444 | ||
| CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis | Q28678344 | ||
| Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant. | Q33188469 | ||
| Immunohistological analysis of the synovial membrane: search for predictors of the clinical course in rheumatoid arthritis | Q33563899 | ||
| Intramuscular gold decreases cytokine expression and macrophage numbers in the rheumatoid synovial membrane | Q33566324 | ||
| Deficiency of CXCR2, but not other chemokine receptors, attenuates autoantibody-mediated arthritis in a murine model | Q34365089 | ||
| CXCL16-mediated cell recruitment to rheumatoid arthritis synovial tissue and murine lymph nodes is dependent upon the MAPK pathway | Q34652416 | ||
| Chemokines in lymphocyte trafficking and intestinal immunity | Q35173622 | ||
| Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes | Q35200770 | ||
| Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis | Q35553008 | ||
| Rheumatoid arthritis: regulation of synovial inflammation | Q35612472 | ||
| Chemokines and their receptors in rheumatoid arthritis: future targets? | Q36063483 | ||
| Chemokines: their role in rheumatoid arthritis | Q36262470 | ||
| Anti-TNF therapy: where have we got to in 2005? | Q36301866 | ||
| Macrophages in rheumatoid arthritis | Q36748422 | ||
| Chemokines and their receptors: drug targets in immunity and inflammation | Q36947059 | ||
| Macrophage scavenger receptors and host-derived ligands | Q36963139 | ||
| Platelet chemokines in vascular disease | Q37131719 | ||
| Anti-chemokine small molecule drugs: a promising future? | Q37683772 | ||
| GSK-1605786, a selective small-molecule antagonist of the CCR9 chemokine receptor for the treatment of Crohn's disease. | Q37768093 | ||
| Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis | Q39701973 | ||
| CCL25 mediates the localization of recently activated CD8alphabeta(+) lymphocytes to the small-intestinal mucosa | Q39737286 | ||
| Retinoid X receptor agonists inhibit phorbol-12-myristate-13-acetate (PMA)-induced differentiation of monocytic THP-1 cells into macrophages | Q39794419 | ||
| Effects of methotrexate on differentiation of monocytes and production of cytokine inhibitors by monocytes | Q40995713 | ||
| A chemokine-dependent stromal induction mechanism for aberrant lymphocyte accumulation and compromised lymphatic return in rheumatoid arthritis | Q41838799 | ||
| CD36 and CD14 immunoreactivity of Reiter cells in inflammatory synovial fluids | Q42849669 | ||
| Adsorptive granulocyte/monocyte apheresis for the treatment of refractory rheumatoid arthritis: an open pilot multicentre trial | Q46520766 | ||
| Cytokines in rheumatoid arthritis. Potential targets for pharmacological intervention | Q48027852 | ||
| Interaction between synovial inflammatory tissue and bone marrow in rheumatoid arthritis. | Q53663064 | ||
| CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn's disease. | Q55034978 | ||
| P433 | issue | 4 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | R161 | |
| P577 | publication date | 2010-08-25 | |
| P1433 | published in | Arthritis Research and Therapy | Q15757229 |
| P1476 | title | Monocytes/macrophages express chemokine receptor CCR9 in rheumatoid arthritis and CCL25 stimulates their differentiation | |
| P478 | volume | 12 |
| Q34363191 | Abrogation of CC chemokine receptor 9 ameliorates collagen-induced arthritis of mice |
| Q37227823 | Abrogation of CC chemokine receptor 9 ameliorates ventricular remodeling in mice after myocardial infarction |
| Q54285108 | Altered expression of intestinal human leucocyte antigen D-related and immune signalling molecules in juvenile idiopathic arthritis. |
| Q45895187 | C-C motif chemokine receptor 9 positive macrophages activate hepatic stellate cells and promote liver fibrosis in mice. |
| Q45892815 | CCL25/CCR9 interactions are not essential for colitis development but are required for innate immune cell protection from chronic experimental murine colitis. |
| Q92230099 | Circadian Regulation of Cochlear Sensitivity to Noise by Circulating Glucocorticoids |
| Q57719084 | Enhanced CCR9 expression levels in psoriatic skin are associated with poor clinical outcome to infliximab treatment |
| Q39024735 | Establishment of an in vitro three-dimensional model for cartilage damage in rheumatoid arthritis. |
| Q42122500 | HLA-DR(hi) and CCR9 Define a Pro-Inflammatory Monocyte Subset in IBD. |
| Q47822234 | Mycobacterium tuberculosis escapes from the phagosomes of infected human osteoclasts reprograms osteoclast development via dysregulation of cytokines and chemokines. |
| Q37718274 | Orphan receptor GPR15/BOB is up-regulated in rheumatoid arthritis |
| Q28248592 | Oxidized lipids and lysophosphatidylcholine induce the chemotaxis, up-regulate the expression of CCR9 and CXCR4 and abrogate the release of IL-6 in human monocytes |
| Q37109535 | Rainbow trout CK9, a CCL25-like ancient chemokine that attracts and regulates B cells and macrophages, the main antigen presenting cells in fish |
| Q90221678 | The role of chemokine receptor 9/chemokine ligand 25 signaling: From immune cells to cancer cells |
| Q28589300 | Toll-like receptor-mediated IRE1α activation as a therapeutic target for inflammatory arthritis |
Search more.